Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
Clinical trial NCT04270591 · RECRUITING
Trial details
- NCT number
- NCT04270591
- Sponsor
- Haihe Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2023-10-25
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.